|
Re: Long time that we’ve seen a post!
|
2
|
Resverlogix Corp.
|
Oct 19, 2023 03:41PM
|
|
Re: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
|
2
|
Resverlogix Corp.
|
Mar 15, 2017 08:16AM
|
|
Re: 2 year extension
|
2
|
Resverlogix Corp.
|
May 14, 2024 02:06PM
|
|
Re: 2 year extension
|
2
|
Resverlogix Corp.
|
May 14, 2024 02:06PM
|
|
Re: Irrational exuberance
|
2
|
Resverlogix Corp.
|
Sep 17, 2020 08:26PM
|
|
Re: 2 year extension
|
2
|
Resverlogix Corp.
|
May 14, 2024 03:28PM
|
|
Re: New compound - ApaBearDownAzone
|
2
|
Resverlogix Corp.
|
Jun 01, 2017 03:31PM
|
|
Re: Naz listing requirements....
|
2
|
Resverlogix Corp.
|
Sep 06, 2018 11:54AM
|
|
Re: 5 million shares
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 09:54AM
|
|
Re: RVV insider purchases
|
2
|
Resverlogix Corp.
|
Dec 12, 2022 10:20PM
|
|
Re: 5 million shares
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 09:59AM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 07:57PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 08:33PM
|
|
Re: MERCK….
|
2
|
Resverlogix Corp.
|
Oct 04, 2021 10:50AM
|
|
Re: SF
|
2
|
Resverlogix Corp.
|
Sep 16, 2020 06:34PM
|
|
Re: FDA approves BetOnMace in US
|
2
|
Resverlogix Corp.
|
Jul 25, 2017 09:07AM
|
|
Resverlogix Announces Third Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone and Provides an Update on Corpo
|
3
|
Resverlogix Corp.
|
Mar 17, 2017 07:30AM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 09, 2021 05:47PM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
3
|
Resverlogix Corp.
|
Oct 04, 2023 10:05AM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
3
|
Resverlogix Corp.
|
Dec 18, 2021 11:23PM
|
